Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies

Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies

US Patent 10882904 · Granted Jan 5, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biochemical probes attached to epoxy-based resins2025
Compositions and methods for growth factor modulation2025
RGMC-selective inhibitors and use thereof2025
Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitors2025
LTBP complex-specific inhibitors of TGFβ and uses thereof2024
Isoform-selective TGFB1 inhibitors and use thereof2024
Methods for altering body composition by administering anti-pro/latent myostatin2024
Methods for altering body composition by administering anti-pro/latent myostatin2024
Methods for altering body composition by administering anti-pro/latent myostatin2024
Compositions for making and using anti-Myostatin antibodies2024
Compositions and methods for growth factor modulation2023
Methods for using anti-myostatin antibodies2022